The $350 deal includes medicated feed additive products, certain water soluble products, and related assets.
Photo: Jonatan Rundblad/Adobe Stock
Phibro Animal Health will acquire Zoetis’ medicated feed additive (MFA) product portfolio, certain water soluble products and related assets for $350 million. The 2 parties announced the definitive agreement on Sunday, April 28, 2024, in a joint news release.
The product portfolio is comprised of more than 37 product lines that are sold in ap
This post WAS generated by Author with the help of AI .
Phibro Animal Health will acquire product portfolio from Zoetis
Related articles